Implantable Drug Delivery Devices Market Is Likely to Experience a Strong Growth During 2021-2026

The report entitled; “Implantable Drug Delivery Devices Market, Trends, Dynamics, and Market Analysis,” recently published by Stratview Research offers a comprehensive outlook of the industry. This report by Product (Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug-Eluting Stents, Bioabsorbable Stents, Intraocular Implants, Infusion Pumps, Others), By Technology (Diffusion, Osmotic, Magnetic, Others), By Application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Others) and Region - COVID-19 Impact Analysis and Forecast to 2026

According to the report, The Implantable Drug Delivery Devices Market is estimated to grow from USD 10.6 billion in 2020 to USD 16.7 billion by 2026 at a healthy CAGR of 8.0% during the forecast period.

How does this report help?

Reports published by Stratview Research help users in several ways. The user can –

-          Gain a deeper understanding of the market and the impact of Covid-19 on the market.

-          Get rigorous analysis and progressive insights into the market across the globe.

-          Assess current and future market trends, and challenges of the market.

-          Gain a comprehensive view on the growth strategies of the key players.

-          Get updates related to recent changes, M&As, new product launches and many such news related to the market, and even more.

Market Segmentation Analysis -

Based on application, the market has been classified into contraception, ophthalmology, cardiovascular, diabetes, oncology, autoimmune diseases, and others. The cardiovascular segment accounted for a substantial market share in 2020. This is mainly attributed to an increase in the patient population suffering from cardiovascular diseases, which boosts the clinical urgency to develop advanced devices. As a result, global players have developed bioabsorbable stents which are gradually absorbed and excreted by the body, further bolstering the segment growth.

The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the strong presence of well-developed healthcare infrastructure, increasing investment in R&D activities, the strong prevalence of cardiovascular diseases, higher adoption of these technologies, and favorable government initiatives. Moreover, the favorable reimbursement policies, high rate of R&D activities, and extensive new development activities, further proliferates the regional growth.

Wish to get a free sample:

Key Players

The following are the key players in the market-

  • Allergan PLC (UK)

  • Boston Scientific Corporation (US)

  • Bausch and Lomb Inc. (Canada)

  • Medtronic PLC (UK)

  • Alcon Inc. (Switzerland)

  • Teleflex Incorporated (US)

  • DSM Biomedical (Netherlands)

  • Delpor Inc. (US)

  • 3M Company (US)

Research Methodology

Stratview Research's reports are the result of a thorough analysis that combines thorough secondary, and primary interviews with industry leaders, and confirmation using unique internal database and statistical methods. More than 1,000 verified secondary sources, such as annual reports from companies, press releases, fact books, journals, white papers, and blogs are reviewed and analysed.

About Stratview Research -

Stratview Research is one of the leading providers of custom and syndicated market research reports. We also offer services like Sourcing, Market Entry Strategy, Target Screening, Voice of Market Study, and much more. In case of any requirement related to market assessment, competitive benchmarking, and others, please send your inquiry to the team.

Email at -

Connect with the analysts at - +1-313-307-4176.